Ratings St Barbara Limited OTC Markets

Equities

STBMF

AU000000SBM8

Market Closed - OTC Markets 09:07:08 30/05/2024 pm IST 5-day change 1st Jan Change
0.16 USD -20.00% Intraday chart for St Barbara Limited -20.00% +57.02%

Summary

  • On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
  • From a short-term investment perspective, the company presents a deteriorated fundamental configuration.

Strengths

  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.1 for the 2024 fiscal year.
  • The company's share price in relation to its net book value makes it look relatively cheap.
  • Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
  • Over the past four months, analysts' average price target has been revised upwards significantly.

Weaknesses

  • As estimated by analysts, this group is among those businesses with the lowest growth prospects.
  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • The company has insufficient levels of profitability.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
  • Most analysts recommend that the stock should be sold or reduced.
  • Over the past twelve months, analysts' consensus has been significantly revised downwards.
  • Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
  • The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Ratings chart - Surperformance

Sector: Gold

1st Jan change Capi. Investor Rating ESG Refinitiv
+57.02% 13Cr -
+1.35% 4.83TCr
A-
+24.36% 3.4TCr
B
-2.88% 2.99TCr
B+
+14.20% 2.48TCr
B
+5.13% 1.09TCr
B
+29.43% 1.01TCr
B-
+38.03% 997.17Cr
A-
-.--% 876.99Cr -
B-
+5.98% 842.63Cr
B-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes